UA75039C2 - Taxanes having an ester substituent at c10, pharmaceutical composition based thereon and a method for inhibiting tumors growth - Google Patents

Taxanes having an ester substituent at c10, pharmaceutical composition based thereon and a method for inhibiting tumors growth Download PDF

Info

Publication number
UA75039C2
UA75039C2 UA2001106733A UA2001106733A UA75039C2 UA 75039 C2 UA75039 C2 UA 75039C2 UA 2001106733 A UA2001106733 A UA 2001106733A UA 2001106733 A UA2001106733 A UA 2001106733A UA 75039 C2 UA75039 C2 UA 75039C2
Authority
UA
Ukraine
Prior art keywords
pyridyl
furyl
thienyl
substituted
taxane
Prior art date
Application number
UA2001106733A
Other languages
English (en)
Ukrainian (uk)
Original Assignee
Univ Florida State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida State Res Found filed Critical Univ Florida State Res Found
Publication of UA75039C2 publication Critical patent/UA75039C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00Containers or packages with special means for dispensing contents
    • B65D83/14Containers for dispensing liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant
    • B65D83/75Aerosol containers not provided for in groups B65D83/16 - B65D83/74
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mechanical Engineering (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
UA2001106733A 2000-02-02 2001-02-02 Taxanes having an ester substituent at c10, pharmaceutical composition based thereon and a method for inhibiting tumors growth UA75039C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17978200P 2000-02-02 2000-02-02
PCT/US2001/003623 WO2001057032A1 (en) 2000-02-02 2001-02-02 C10 ester substituted taxanes as antitumor agents

Publications (1)

Publication Number Publication Date
UA75039C2 true UA75039C2 (en) 2006-03-15

Family

ID=22657972

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2001106733A UA75039C2 (en) 2000-02-02 2001-02-02 Taxanes having an ester substituent at c10, pharmaceutical composition based thereon and a method for inhibiting tumors growth

Country Status (25)

Country Link
EP (1) EP1165553B1 (https=)
JP (1) JP2003522172A (https=)
CN (1) CN1380882A (https=)
AT (1) ATE432928T1 (https=)
AU (1) AU782150B2 (https=)
BG (1) BG64889B1 (https=)
BR (1) BR0104354A (https=)
CA (1) CA2368274C (https=)
CZ (1) CZ20013430A3 (https=)
DE (1) DE60138853D1 (https=)
GE (1) GEP20043323B (https=)
HU (1) HUP0600302A2 (https=)
IL (1) IL145638A (https=)
MX (1) MXPA01009905A (https=)
NO (1) NO327910B1 (https=)
NZ (1) NZ514382A (https=)
PL (1) PL202957B1 (https=)
RO (1) RO121270B1 (https=)
RU (1) RU2262506C2 (https=)
SK (1) SK13692001A3 (https=)
TR (1) TR200102858T1 (https=)
TW (1) TWI299732B (https=)
UA (1) UA75039C2 (https=)
WO (1) WO2001057032A1 (https=)
ZA (1) ZA200108055B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649632B2 (en) 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
CA2354471A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C10 ester substituted taxanes
SG129990A1 (en) * 2001-08-01 2007-03-20 Univ Florida State Res Found C10 ester substituted taxanes
HN2005000054A (es) 2004-02-13 2009-02-18 Florida State University Foundation Inc Taxanos sustituidos con esteres de ciclopentilo en c10
US20060189679A1 (en) * 2005-02-14 2006-08-24 Florida State University Research Foundation, Inc. C10 cyclopropyl ester substituted taxane compositions
JP2011517455A (ja) * 2008-03-31 2011-06-09 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド C(10)エチルエステルおよびc(10)シクロプロピルエステル置換タキサン

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US5250683A (en) * 1991-09-23 1993-10-05 Florida State University Certain substituted taxanes and pharmaceutical compositions containing them
US5243045A (en) * 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
IL108443A0 (en) * 1993-01-29 1994-04-12 Univ Florida State C7 taxane derivatives and pharmaceutical compositions containing them
IL109051A0 (en) * 1993-03-22 1994-06-24 Univ Florida State Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them
ATE284689T1 (de) * 1993-03-22 2005-01-15 Univ Florida State Pharmazeutische zusammenstellungen enthaltende eine furyl oder thienyl substituierte seitenkette
ATE209489T1 (de) * 1993-03-22 2001-12-15 Univ Florida State Taxane mit pyridyl-substituierter seitenkette
US5475011A (en) * 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
US6100411A (en) * 1994-10-28 2000-08-08 The Research Foundation Of State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
EP0788493A1 (en) * 1994-10-28 1997-08-13 The Research Foundation Of State University Of New York Taxoid derivatives, their preparation and their use as antitumor agents
WO1997044026A1 (en) * 1996-05-22 1997-11-27 Neuromedica, Inc. Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
CA2314071A1 (en) * 1997-12-19 1999-07-01 Kabushiki Kaisha Yakult Honsha Taxane derivatives
JP2003026673A (ja) * 1999-03-05 2003-01-29 Asahi Kasei Corp 骨形成促進剤

Also Published As

Publication number Publication date
IL145638A (en) 2011-05-31
PL351380A1 (en) 2003-04-07
NZ514382A (en) 2004-05-28
SK13692001A3 (sk) 2002-07-02
PL202957B1 (pl) 2009-08-31
NO20014754L (no) 2001-11-29
NO327910B1 (no) 2009-10-19
EP1165553B1 (en) 2009-06-03
BG64889B1 (bg) 2006-08-31
TWI299732B (en) 2008-08-11
BR0104354A (pt) 2002-01-02
CZ20013430A3 (cs) 2002-04-17
CN1380882A (zh) 2002-11-20
TR200102858T1 (tr) 2002-12-23
CA2368274A1 (en) 2001-08-09
WO2001057032A1 (en) 2001-08-09
AU3480901A (en) 2001-08-14
CA2368274C (en) 2009-10-13
GEP20043323B (en) 2004-02-10
IL145638A0 (en) 2002-06-30
NO20014754D0 (no) 2001-10-01
JP2003522172A (ja) 2003-07-22
EP1165553A1 (en) 2002-01-02
BG105965A (en) 2002-07-31
MXPA01009905A (es) 2003-08-20
AU782150B2 (en) 2005-07-07
HUP0600302A2 (en) 2006-07-28
DE60138853D1 (de) 2009-07-16
ZA200108055B (en) 2003-12-01
ATE432928T1 (de) 2009-06-15
RO121270B1 (ro) 2007-02-28
RU2262506C2 (ru) 2005-10-20

Similar Documents

Publication Publication Date Title
KR100784161B1 (ko) 항종양제로서 c7 에스테르 치환된 탁산
RU2264400C2 (ru) Таксан, фармацевтическая композиция на его основе и способ ингибирования роста опухоли
AU776765B2 (en) C7 heterosubstituted acetate taxanes as antitumor agents
RU2265019C2 (ru) Таксаны, фармацевтические композиции, способы ингибирования
UA75039C2 (en) Taxanes having an ester substituent at c10, pharmaceutical composition based thereon and a method for inhibiting tumors growth
CZ20013521A3 (cs) C7 karbamoyloxy substituované taxany jako protinádorové látky
CN100491363C (zh) C7酯取代的紫杉烷
KR100819578B1 (ko) C7 에스테르 치환된 탁산
US20050209311A1 (en) C7 lactyloxy-substituted taxanes
KR20030012508A (ko) C10 에스테르 치환된 탁산